Back to search

Netherlands· NL-a24f96719033

Ofloxacine Stulln Unit Dose 3 mg/ml oogdruppels, oplossing

A ofloxacin product containing ofloxacine, registered in Netherlands by Pharma Stulln GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC S01AE01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOfloxacine Stulln Unit Dose 3 mg/ml o…ATCS01AE01REGISTER NO.NL-a24f96719033PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Ofloxacin is registered in 11 of 19 countries.

Countries holding a registration under ATC S01AE01 (ofloxacin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Ofloxacin · ATC S01AE01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
OFLOXACINE
Manufacturer
Pharma Stulln GmbH
Country
Netherlands (NL)
ATC code
S01AE01
ATC class
Ofloxacin
Defined daily dose
0.4 mg, AT
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    109912

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ofloxacin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ofloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Floxal, Floxal Edo
  • Belgium · Trafloxal, Trafloxal Edo
  • Bulgaria · Медофлоксин, Офлоксацин Дра
  • Cyprus · Cilox, Medofloxine
  • Czechia · Floxal, Ofloxacin Unimed Pharma
  • Germany · Floxal, Floxal Edo
  • Estonia · Medofloxine, Ofloxin
  • Spain · Exocin, Oflovir
  • Finland · Exocin
  • France · Exocine, Monoflocet
  • United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
  • Greece · Exocin, Oxatrex
  • Croatia · Uniflox
  • Hungary · Floxal, Grenis-Oflo
  • Ireland · Exocin
  • Italy · Dunaflot, Exocin
  • Lithuania · Ofloxin, Uniflox
  • Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
  • Latvia · Ofloxin, Uniflox
  • Malta · Uniflox Unimed Pharma
  • Poland · Floxal, Oflodinex
  • Portugal · Audret, Bioquil
  • Romania · Floxal, Ofloxacină Laropharm
  • Sweden · Ofloxacin Mibe
  • Slovakia · Medofloxine, Ofloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3297cf5-b8e2-4042-8ff3-cf37c158e53a
GET /v1/drugs/b3297cf5-b8e2-4042-8ff3-cf37c158e53a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h109912_smpc.pdf",
  "strength": null,
  "atc_label": "Ofloxacin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg109912",
  "excipients": [
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "OFLOXACINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h109912.pdf",
  "authorised_at": "2012/11/26",
  "procedure_number": "NL/H/2393/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "109912",
  "additional_monitoring": "N"
}

See everything about ofloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.